Immune response to cancer cells
Mineral adjuvants for vaccination in oncology
Article REF: N4965 V1
Immune response to cancer cells
Mineral adjuvants for vaccination in oncology

Author : Patrick FRAYSSINET

Publication date: April 10, 2014 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

1. Immune response to cancer cells

To understand the mode of action of adjuvant materials in vaccines and the choice of their characteristics, we need to return to the mechanism of the immune response. The immune response to an antigen and to an antigen synthesized by a cancer cell can be diagrammed as shown in figure 1 .

Under normal conditions, tumor cells are spontaneously recognized by tissue-resident NK (natural killer) cells. This process is part of innate immunity. The acquired immune response, specific to an antigen or group of antigens, is mediated by antigen-presenting cells: macrophages and, above all, dendritic cells. These cells monitor circulating molecules and organisms, and after phagocytosis of these organisms, express proteins belonging to them on their surface. These abnormal proteins are recognized by immune...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Healthcare technologies"

( 124 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us